Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Market Update
-
New data with daridorexant to be presented at SLEEP 2024
-
Corbion reports the progress of its € 20 million share buyback program 27 May – 31 May 2024
-
ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies
-
Ipsen initiates a share buy-back program to cover its free employee share-allocation plan
-
Ontex finalizes the divestment of its business in Pakistan
-
Asia Green Fund U.S.-China Green Fund I Partner Conference 2023 is Successfully Held in Beijing
-
Flash News: OKX to Support Mina Protocol's Upgrade
-
Flash News: OKX to Support Mina Protocol's Upgrade
-
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
-
Upcoming Acer Swift Series Laptops to Feature Models with New AMD Ryzen AI 300 Series Processors
-
Dreya Starr's Newest Releases!
-
Pickleball Paradise hits the musical market
-
ASHTON-DRAKE RELEASES PREMIUM "RUDOLPH THE RED-NOSED REINDEER®" MASTERPIECE FIGURE COLLECTION
-
HO CHI MINH CITY RIVER FESTIVAL EXPANDS IN SCALE, IGNITING SUMMER TOURISM IN 2024
-
NetAlly Unveils Next Generation LinkRunner® AT Network and Cable Testers
-
Private equity finds a footing but still searching for momentum as two-year slump bottoms out--Bain & Company's PE Midyear Report
-
Triumph Motorcycle Dealers Ranked First in Industry Study for Providing Quick and Easy Service Appointments
-
Sigma 28-45mm F1.8 Full Frame DG DN Art Lens Announced; YouTube Video First Look, Learn More Info at B&H Photo Video
-
ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests
-
10 Fitness Guarantees Uninterrupted Gym Access with SARA, Even After Hours
-
IXOPAY Appoints Brady Harris as CEO to Drive Global Payments Growth
-
BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage
-
MGI Tech's DNBSEQ-E25 and G99 Platforms Set Record for Sequencing Applications on Mount Everest
-
The9 Signed a Definitive Share Purchase Agreement to Invest in AI-Powered Educational Technology Company
-
TOYOTA GAZOO Racing and Ogier denied in dramatic finish
-
AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
-
AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Roadmap
-
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen and EPYC Processors at Computex 2024
-
Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved Outstanding Phase II Results, Has Been Presented in Clinical Science Symposium at 2024 ASCO Ann
-
Appointment of Director to Woodside Board
-
NOTICE OF THE TWENTY-FIFTH ANNUAL GENERAL MEETING OF SHAREHOLDERS
-
Fujitsu Japan and Juntendo University launch joint research for disaster-resilient, digital medical system
-
2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
-
Flash News: OKX Launches 100% Fee Rebate Campaign
-
Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in Japan
-
LaVie Care Centers Takes Strategic Actions to Position the Company for Long-Term Success Amidst Challenging Skilled Nursing Operating Environment
-
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatme
-
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer a
-
SATO Technologies Corp. Reports Limited Incident at the Building Hosting Data Center One
-
China Medical University Hospital (CMUH, Taiwan) Signs MOU with Malaysian International Medical University
-
Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis
-
TECNO exhibits its diverse smartphone and AIoT ecosystem with futuristic AR and AI products at COMPUTEX Taipei 2024, with the concept "Smart of Creation"
-
MSI Unveils New AI and Computing Platforms with 4th Gen AMD EPYC™ Processors at Computex 2024
-
Nissan Demonstrates Autonomous-Drive Mobility Services Progress on Public Roads
-
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial
-
WEBTOON Entertainment Announces Public Filing of Registration Statement for Proposed Initial Public Offering
-
Mesoblast Corporate Presentation at Investor Conference
-
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
-
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
